Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples